A detailed history of Peregrine Asset Advisers, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Peregrine Asset Advisers, Inc. holds 15,585 shares of MRK stock, worth $1.52 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
15,585
Previous 14,235 9.48%
Holding current value
$1.52 Million
Previous $1.76 Million 0.4%
% of portfolio
0.62%
Previous 0.72%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$111.15 - $128.97 $150,052 - $174,109
1,350 Added 9.48%
15,585 $1.77 Million
Q1 2024

May 02, 2024

SELL
$113.24 - $131.95 $822,575 - $958,484
-7,264 Reduced 33.79%
14,235 $1.88 Million
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $702,662 - $764,666
7,014 Added 48.42%
21,499 $2.34 Million
Q3 2023

Oct 31, 2023

BUY
$102.95 - $114.33 $1.49 Million - $1.66 Million
14,485 New
14,485 $1.49 Million
Q2 2022

Aug 09, 2022

BUY
$83.49 - $94.64 $3.15 Million - $3.57 Million
37,756 New
37,756 $3.44 Million
Q1 2022

May 05, 2022

SELL
$73.51 - $82.4 $2.01 Million - $2.25 Million
-27,286 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$72.28 - $90.54 $1.97 Million - $2.47 Million
27,286 New
27,286 $2.09 Million
Q4 2020

Feb 04, 2021

SELL
$71.77 - $79.65 $3.71 Million - $4.11 Million
-51,639 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $3.78 Million - $4.28 Million
51,639 New
51,639 $4.28 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $121,122 - $137,823
-1,720 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $108,979 - $151,050
1,720 New
1,720 $132,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Peregrine Asset Advisers, Inc. Portfolio

Follow Peregrine Asset Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Asset Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Asset Advisers, Inc. with notifications on news.